Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : GUMM - Eliminate the Common Cold -- Ignore unavailable to you. Want to Upgrade?

To: out_of_the_loop who wrote (810)	8/28/1999 2:22:00 PM
From: Mad2	Read Replies (1) \| Respond to of 5582

Howard 18 months ago PIB (polyisobutylene) was on allocation. It comes from Exxon and and (I believe Bayer) in Germany.....stated reason from suppliers was demand in chewing gum. No new customers and supply allocated based on past years demand. While that's not a issue today, just the basics of packaging (printed) and material control when one is producing product with unknown demand creates problems of predicting demand. Long lead times hamper marketing efforts as product moves from production to warehouse distribution and finally to the store. Enough said...dammage generally comes not during ramp up but once the supply chain is filled and demand slacks off. Mad2